FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000470201> ?p ?o ?g. }

• W2000470201 endingPage "2348" @default.
• W2000470201 startingPage "2344" @default.
• W2000470201 abstract "Gefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor that induces an early and dramatic response in 10% of patients with advanced nonsmall cell lung carcinoma (NSCLC). Long- term outcome and patterns of disease recurrence after response have not been described.The authors evaluated 139 patients with NSCLC treated with gefitinib at Memorial Sloan-Kettering Cancer Center (New York, NY) between 1998 and 2002. They focused on patterns of disease recurrence, risk of brain metastases (BM) and leptomeningeal metastasis (LM), and long-term outcome after initial response to gefitinib.Of the 139 patients treated with gefitinib, 21 (15%) achieved a partial response. The median age of the responders was 64 years (range, 38-87 years), the median Karnofsky performance score was 80 (range, 60-90), and 4 of the patients were men. All responders had adenocarcinoma. The central nervous system (CNS) was the initial site of disease recurrence in 7 (33%) patients (BM in 5 and LM in 2). In 9 (43%) patients, the initial site of disease recurrence was the lung and in 1 it was the liver and bone. Four (57%) of the patients with disease recurrence in the CNS had lung disease under control. BM also developed in 2 patients who had initial disease recurrence in the lungs. The actuarial 5-year incidence of CNS metastases was 60%. The median overall survival periods were 15 months and 23 months for patients with and without CNS metastases, respectively (P = 0.24).The CNS was a frequent site of disease recurrence in patients with NSCLC after an initial response to gefitinib, regardless of disease control in the lungs. Patients should be carefully monitored for neurologic symptoms. Intrinsic resistance of metastatic clones, incomplete CNS penetrance of the drug, and longer survival are possible explanations for this high incidence." @default.
• W2000470201 created "2016-06-24" @default.
• W2000470201 creator A5010443739 @default.
• W2000470201 creator A5033270808 @default.
• W2000470201 creator A5035120516 @default.
• W2000470201 creator A5039791495 @default.
• W2000470201 creator A5046345302 @default.
• W2000470201 creator A5063327760 @default.
• W2000470201 creator A5084965180 @default.
• W2000470201 date "2005-01-01" @default.
• W2000470201 modified "2023-09-29" @default.
• W2000470201 title "High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib" @default.
• W2000470201 cites W1981692336 @default.
• W2000470201 cites W1982372171 @default.
• W2000470201 cites W1990936385 @default.
• W2000470201 cites W2013070755 @default.
• W2000470201 cites W2017550329 @default.
• W2000470201 cites W2042702856 @default.
• W2000470201 cites W2043696829 @default.
• W2000470201 cites W2051767374 @default.
• W2000470201 cites W2111710483 @default.
• W2000470201 cites W2120718661 @default.
• W2000470201 cites W2129455899 @default.
• W2000470201 cites W2139236349 @default.
• W2000470201 cites W2145653040 @default.
• W2000470201 cites W2146404049 @default.
• W2000470201 cites W2161821474 @default.
• W2000470201 cites W2167368130 @default.
• W2000470201 cites W2200358793 @default.
• W2000470201 cites W3190307202 @default.
• W2000470201 doi "https://doi.org/10.1002/cncr.21033" @default.
• W2000470201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15844174" @default.
• W2000470201 hasPublicationYear "2005" @default.
• W2000470201 type Work @default.
• W2000470201 sameAs 2000470201 @default.
• W2000470201 citedByCount "205" @default.
• W2000470201 countsByYear W20004702012012 @default.
• W2000470201 countsByYear W20004702012013 @default.
• W2000470201 countsByYear W20004702012014 @default.
• W2000470201 countsByYear W20004702012015 @default.
• W2000470201 countsByYear W20004702012016 @default.
• W2000470201 countsByYear W20004702012017 @default.
• W2000470201 countsByYear W20004702012018 @default.
• W2000470201 countsByYear W20004702012019 @default.
• W2000470201 countsByYear W20004702012020 @default.
• W2000470201 countsByYear W20004702012021 @default.
• W2000470201 countsByYear W20004702012022 @default.
• W2000470201 countsByYear W20004702012023 @default.
• W2000470201 crossrefType "journal-article" @default.
• W2000470201 hasAuthorship W2000470201A5010443739 @default.
• W2000470201 hasAuthorship W2000470201A5033270808 @default.
• W2000470201 hasAuthorship W2000470201A5035120516 @default.
• W2000470201 hasAuthorship W2000470201A5039791495 @default.
• W2000470201 hasAuthorship W2000470201A5046345302 @default.
• W2000470201 hasAuthorship W2000470201A5063327760 @default.
• W2000470201 hasAuthorship W2000470201A5084965180 @default.
• W2000470201 hasConcept C121608353 @default.
• W2000470201 hasConcept C126322002 @default.
• W2000470201 hasConcept C143998085 @default.
• W2000470201 hasConcept C2776256026 @default.
• W2000470201 hasConcept C2777546739 @default.
• W2000470201 hasConcept C2777714996 @default.
• W2000470201 hasConcept C2778164965 @default.
• W2000470201 hasConcept C2778822529 @default.
• W2000470201 hasConcept C2779013556 @default.
• W2000470201 hasConcept C2779134260 @default.
• W2000470201 hasConcept C2779438470 @default.
• W2000470201 hasConcept C2780580887 @default.
• W2000470201 hasConcept C2781182431 @default.
• W2000470201 hasConcept C71924100 @default.
• W2000470201 hasConcept C90924648 @default.
• W2000470201 hasConceptScore W2000470201C121608353 @default.
• W2000470201 hasConceptScore W2000470201C126322002 @default.
• W2000470201 hasConceptScore W2000470201C143998085 @default.
• W2000470201 hasConceptScore W2000470201C2776256026 @default.
• W2000470201 hasConceptScore W2000470201C2777546739 @default.
• W2000470201 hasConceptScore W2000470201C2777714996 @default.
• W2000470201 hasConceptScore W2000470201C2778164965 @default.
• W2000470201 hasConceptScore W2000470201C2778822529 @default.
• W2000470201 hasConceptScore W2000470201C2779013556 @default.
• W2000470201 hasConceptScore W2000470201C2779134260 @default.
• W2000470201 hasConceptScore W2000470201C2779438470 @default.
• W2000470201 hasConceptScore W2000470201C2780580887 @default.
• W2000470201 hasConceptScore W2000470201C2781182431 @default.
• W2000470201 hasConceptScore W2000470201C71924100 @default.
• W2000470201 hasConceptScore W2000470201C90924648 @default.
• W2000470201 hasIssue "11" @default.
• W2000470201 hasLocation W20004702011 @default.
• W2000470201 hasLocation W20004702012 @default.
• W2000470201 hasOpenAccess W2000470201 @default.
• W2000470201 hasPrimaryLocation W20004702011 @default.
• W2000470201 hasRelatedWork W1602357875 @default.
• W2000470201 hasRelatedWork W1821084576 @default.
• W2000470201 hasRelatedWork W2014330130 @default.
• W2000470201 hasRelatedWork W2186047679 @default.
• W2000470201 hasRelatedWork W2274176250 @default.
• W2000470201 hasRelatedWork W2413589460 @default.
• W2000470201 hasRelatedWork W2802661326 @default.

• next